Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are LIF and related cytokines functionally equivalent?

C Piquet-Pellorce1, L Grey, A Mereau

  • 1Department of Biochemistry, University of Oxford, United Kingdom.

Experimental Cell Research
|August 1, 1994
PubMed
Summary

Leukemia inhibitory factor (LIF) and related cytokines like IL-6 and OSM have distinct biological actions. These factors are not interchangeable, as they exhibit unique effects on embryonic stem cell growth, hybridoma cell proliferation, and acute-phase protein production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental approaches to studying the nature and impact of splicing variation in zebrafish.

Methods in cell biology·2016
Same author

TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

Cell death and differentiation·2012
Same author

Determining the LIF-sensitive period for implantation using a LIF-receptor antagonist.

Reproduction (Cambridge, England)·2009
Same author

A mass action model of a Fibroblast Growth Factor signaling pathway and its simplification.

Bulletin of mathematical biology·2008
Same author

Interleukin 1 signaling is regulated by leukemia inhibitory factor (LIF) and is aberrant in Lif-/- mouse uterus.

Biology of reproduction·2008
Same author

A simple method allowing DIC imaging in conjunction with confocal microscopy.

Journal of microscopy·2005

Area of Science:

  • Cytokine signaling and receptor interactions.
  • Stem cell biology and differentiation.
  • Cellular responses to growth factors.

Background:

  • Leukemia inhibitory factor (LIF) is structurally similar to interleukin-6 (IL-6), oncostatin M (OSM), and ciliary neurotrophic factor (CNTF).
  • LIF-deficient mice show no overt phenotypic effects, prompting investigation into the functional redundancy of related cytokines.
  • Understanding the specific roles of these cytokines is crucial for applications in regenerative medicine and cell culture.

Purpose of the Study:

  • To evaluate the ability of IL-6, OSM, and CNTF to replicate LIF's effects across various biological assays.
  • To determine the functional specificity and potential interchangeability of LIF and its related cytokines.
  • To investigate cytokine-receptor interactions and downstream cellular responses.

Related Experiment Videos

Main Methods:

  • Comparative analysis of LIF, IL-6, OSM, and CNTF in five distinct bioassays.
  • Assays included: embryonic stem (ES) cell growth and differentiation, hybridoma cell proliferation, DA1a cell proliferation, and hepatoma cell (HepG2) acute-phase protein production.
  • Measurement of alkaline phosphatase activity for ES cell pluripotency and dose-response curves for cell proliferation and protein synthesis.

Main Results:

  • OSM, CNTF, and LIF all support ES cell growth and pluripotency, with varying potencies (ED50: OSM 0.5, LIF 1, CNTF 3 ng/ml).
  • IL-6 uniquely stimulates 7TD1 hybridoma cell growth, while LIF and OSM stimulate DA1a cell proliferation, with OSM showing lower specific activity.
  • IL-6, LIF, and OSM differentially stimulate HepG2 acute-phase protein production; CNTF is effective only at high concentrations. OSM inhibits A549 cell growth, suggesting distinct receptor usage compared to LIF.

Conclusions:

  • None of the examined cytokines (IL-6, OSM, CNTF) are fully interchangeable with LIF, as each exhibits unique biological activities.
  • OSM acts as a weak agonist for some LIF-dependent processes in murine cells but may interact with different receptors in human cells.
  • The distinct dose-response characteristics and cellular effects highlight the specific roles and receptor specificities of these related cytokines.